Bibliography for MD7510 Clinical Presentation & Management in Diabetes: Glycaemic Control, New & Novel Therapies (DL) BETA

‘A Randomised trial of the effect and cost-effectiveness of early intensive mulitfactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diaberes:the anglod-Danish-Dutch Study of intensive Treatment in People with Screen-Detected Diabetes in Primary care (ADDITION-Europe) study.’ (no date). Available at: http://www.journalslibrary.nihr.ac.uk/hta/volume-20/issue-64#abstract.

Amori, R.E., Lau, J. and Pittas, A.G. (2007) ‘Efficacy and Safety of Incretin Therapy in Type 2 Diabetes’, JAMA, 298(2). Available at: https://doi.org/10.1001/jama.298.2.194.

Amy Kennedy (2013) ‘Does Exercise Improve Glycaemic Control in Type 1 Diabetes? A Systematic Review and Meta-Analysis’, PLoS ONE, 8(3). Available at: https://doi.org/doi:  10.1371/journal.pone.0058861.

Anthony H. Barnett, Jenny Grice (2013) New Mechanisms in Glucose Control. BMJ Books; 1 edition. Available at: http://ezproxy.lib.le.ac.uk/login?url=http://lib.myilibrary.com?id=478133.

[ARCHIVED CONTENT] Medicines management: Everybody’s business : Department of Health - Publications and statistics (no date). Available at: http://webarchive.nationalarchives.gov.uk/20080205132320/http:/dh.gov.uk/en/publicationsandstatistics/publications/publicationspolicyandguidance/dh_082200.

Atkinson, M.A. (2012) ‘The Pathogenesis and Natural History of Type 1 Diabetes’, Cold Spring Harbor Perspectives in Medicine, 2(11), pp. a007641–a007641. Available at: https://doi.org/10.1101/cshperspect.a007641.

Avery, L. et al. (2012) ‘Changing Physical Activity Behavior in Type 2 Diabetes: A systematic review and meta-analysis of behavioral interventions’, Diabetes Care, 35(12), pp. 2681–2689. Available at: https://doi.org/10.2337/dc11-2452.

Bailey, C.J. et al. (2010) ‘Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial’, The Lancet, 375(9733), pp. 2223–2233. Available at: https://doi.org/10.1016/S0140-6736(10)60407-2.

Bailey, Stephen (no date) Academic Writing : A Handbook for International Students. Available at: http://lib.myilibrary.com.ezproxy4.lib.le.ac.uk/Open.aspx?id=310467.

Barry, V.W. et al. (2014) ‘Fitness vs. Fatness on All-Cause Mortality: A Meta-Analysis’, Progress in Cardiovascular Diseases, 56(4), pp. 382–390. Available at: https://doi.org/10.1016/j.pcad.2013.09.002.

Bennett, W.L. et al. (2011) ‘Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations’, Annals of Internal Medicine, 154(9). Available at: https://doi.org/10.7326/0003-4819-154-9-201105030-00336.

Bergenstal, R.M. et al. (2010) ‘Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes’, New England Journal of Medicine, 363(4), pp. 311–320. Available at: https://doi.org/10.1056/NEJMoa1002853.

Bethel, M.A. et al. (2017) ‘Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)’, Diabetes Care, 40(4), pp. 494–501. Available at: https://doi.org/10.2337/dc16-1135.

Beverley M Shields (2015) ‘Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature’, BMJ Open, 5(11). Available at: https://doi.org/doi:  10.1136/bmjopen-2015-009088.

Birkeland, K.I. (2015) ‘Hyperglycaemia in pregnancy: still a lot to learn’, The Lancet Diabetes & Endocrinology, 3(10), pp. 752–753. Available at: https://doi.org/10.1016/S2213-8587(15)00282-X.

Brown, J. et al. (1996) ‘Lifestyle interventions for the treatment of women with gestational diabetes’, in Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, Ltd. Available at: https://doi.org/10.1002/14651858.CD011970.pub2.

Buse, J.B. et al. (2009) ‘Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)’, The Lancet, 374(9683), pp. 39–47. Available at: https://doi.org/10.1016/S0140-6736(09)60659-0.

Buse, J.B. et al. (2010) ‘DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks’, Diabetes Care, 33(6), pp. 1255–1261. Available at: https://doi.org/10.2337/dc09-1914.

Buse, J.B. et al. (2011) ‘Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes’, Annals of Internal Medicine, 154(2). Available at: https://doi.org/10.7326/0003-4819-154-2-201101180-00300.

‘Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes | 1-Recommendations | Guidance and guidelines | NICE’ (no date). Available at: https://www.nice.org.uk/guidance/ta390/chapter/1-Recommendations.

Capehorn, M. et al. (2017) ‘Challenges faced by physicians when discussing the Type 2 diabetes diagnosis with patients: insights from a cross-national study (IntroDia                              )’, Diabetic Medicine [Preprint]. Available at: https://doi.org/10.1111/dme.13357.

Chimen, M. et al. (2012) ‘What are the health benefits of physical activity in type 1 diabetes mellitus? A literature review’, Diabetologia, 55(3), pp. 542–551. Available at: https://doi.org/10.1007/s00125-011-2403-2.

Choudhary, P. et al. (2012) ‘Islet cell transplantation: current status in the UK (2012)’, Practical Diabetes, 29(7), pp. 280–285. Available at: https://doi.org/10.1002/pdi.1707.

Constructs of depression and distress in diabetes: time for an appraisal- ClinicalKey (no date). Available at: https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858715001357.

Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review) TA151, July 2008 (no date). Available at: http://www.nice.org.uk/guidance/ta151.

Copeland, K.C. et al. (2013) ‘Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents’, PEDIATRICS, 131(2), pp. 364–382. Available at: https://doi.org/10.1542/peds.2012-3494.

Courtney, H. et al. (2017) ‘Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists’, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Volume 10, pp. 79–87. Available at: https://doi.org/10.2147/DMSO.S126763.

Creme, P. and Lea, M.R. (2008) Writing At University: A Guide For Students. 3rd ed. Maidenhead: McGraw-Hill Education. Available at: https://ebookcentral.proquest.com/lib/leicester/detail.action?pq-origsite=primo&docID=345134.

Dapagliflozin in combination therapy for treating type 2 diabetes June 2013 (no date). Available at: http://www.nice.org.uk/guidance/ta288.

Davies, M. et al. (2017) ‘Introduction of biosimilar insulins in Europe’, Diabetic Medicine, 34(10), pp. 1340–1353. Available at: https://doi.org/10.1111/dme.13400.

Davies, M.J. et al. (2008) ‘Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial’, BMJ, 336(7642), pp. 491–495. Available at: https://doi.org/10.1136/bmj.39474.922025.BE.

Dhatariya, K.K., Skedgel, C. and Fordham, R. (2017) ‘The cost of treating diabetic ketoacidosis in the UK: a national survey of hospital resource use’, Diabetic Medicine, 34(10), pp. 1361–1366. Available at: https://doi.org/10.1111/dme.13427.

Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period  (NG3 (no date). Available at: https://www.nice.org.uk/guidance/ng3.

‘Diagnosis and management of type 1 diabetes in children, young people and adults | Guidance and guidelines | NICE’ (no date). Available at: https://www.nice.org.uk/guidance/cg15.

Diamant, M. et al. (2010) ‘Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial’, The Lancet, 375(9733), pp. 2234–2243. Available at: https://doi.org/10.1016/S0140-6736(10)60406-0.

Dungan, K.M. et al. (2014) ‘Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial’, The Lancet, 384(9951), pp. 1349–1357. Available at: https://doi.org/10.1016/S0140-6736(14)60976-4.

‘Efficacy and Safety of Glucagon-like peptide-1 receptor agonists  in type 2 diabetes  Systematic review and mixed-treatment comparison analysis’ (no date). Available at: http://onlinelibrary.wiley.com.ezproxy3.lib.le.ac.uk/doi/10.1111/dom.12849/epdf.

‘Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes’ (2016) New England Journal of Medicine, 375(18), pp. 1799–1802. Available at: https://doi.org/10.1056/NEJMc1611290.

Exenatide prolonged-release suspension for injection in combination with oral antidiabetic therapy for the treatment of type 2 diabetes | Guidance and guidelines TA 248 Feb 2015 (no date). Available at: https://www.nice.org.uk/guidance/ta248.

‘Exercise and Glucose Metabolism in Persons with Diabetes Mellitus: Perspectives on the Role for Continuous Glucose Monitoring’ (no date) Journal of diabetes science and technology (Online), 3(4). Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769951/.

Fagin, J.A. and Wells, S.A. (2016) ‘Biologic and Clinical Perspectives on Thyroid Cancer’, New England Journal of Medicine, 375(11), pp. 1054–1067. Available at: https://doi.org/10.1056/NEJMra1501993.

Ferrari, M., Dal Cin, M. and Steele, M. (2017) ‘Self-compassion is associated with optimum self-care behaviour, medical outcomes and psychological well-being in a cross-sectional sample of adults with diabetes’, Diabetic Medicine, 34(11), pp. 1546–1553. Available at: https://doi.org/10.1111/dme.13451.

Gale, E.A. (2013) ‘Is type 2 diabetes a category error?’, The Lancet, 381(9881), pp. 1956–1957. Available at: https://doi.org/10.1016/S0140-6736(12)62207-7.

Gallwitz, B. et al. (2012) ‘2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial’, The Lancet, 380(9840), pp. 475–483. Available at: https://doi.org/10.1016/S0140-6736(12)60691-6.

Grammes, J. et al. (2017) ‘Focus group study to identify the central facets of fear of hypoglycaemia in people with Type 2 diabetes mellitus’, Diabetic Medicine [Preprint]. Available at: https://doi.org/10.1111/dme.13506.

Gray, L.J. et al. (2012) ‘Implementation of the automated Leicester Practice Risk Score in two diabetes prevention trials provides a high yield of people with abnormal glucose tolerance’, Diabetologia, 55(12), pp. 3238–3244. Available at: https://doi.org/10.1007/s00125-012-2725-8.

Gray, L.J. et al. (2014) ‘External validation of two diabetes risk scores in a young UK South Asian population’, Diabetes Research and Clinical Practice, 104(3), pp. 451–458. Available at: https://doi.org/10.1016/j.diabres.2014.03.018.

Green, J.B. et al. (2015) ‘Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes’, New England Journal of Medicine, 373(3), pp. 232–242. Available at: https://doi.org/10.1056/NEJMoa1501352.

Gregg, E.W. (2017) ‘The Changing Tides of the Type 2 Diabetes Epidemic—Smooth Sailing or Troubled Waters Ahead? Kelly West Award Lecture 2016’, Diabetes Care [Preprint]. Available at: https://doi.org/10.2337/dci16-0055.

Guidelines (no date). Available at: https://www.idf.org/e-library/guidelines/79-global-guideline-for-type-2-diabetes.

Hadjiconstantinou, M. et al. (2016) ‘Do Web-Based Interventions Improve Well-Being in Type 2 Diabetes? A Systematic Review and Meta-Analysis’, Journal of Medical Internet Research, 18(10). Available at: https://doi.org/10.2196/jmir.5991.

Harman-Boehm, I. (2008) ‘Continuous glucose monitoring in type 2 diabetes’, Diabetes Research and Clinical Practice, 82, pp. S118–S121. Available at: https://doi.org/10.1016/j.diabres.2008.09.051.

Hartman, Y.A.W. et al. (2017) ‘Insulin-Associated Weight Gain in Type 2 Diabetes Is Associated With Increases in Sedentary Behavior’, Diabetes Care, 40(9), pp. e120–e121. Available at: https://doi.org/10.2337/dc17-0787.

Heinonen, I. et al. (2013) ‘Sedentary behaviours and obesity in adults: the Cardiovascular Risk in Young Finns Study’, BMJ Open, 3(6). Available at: https://doi.org/10.1136/bmjopen-2013-002901.

Henson, Joseph (2014) ‘Associations of Sedentary Time with Fat Distribution in a High-Risk Population.’ Available at: https://lra.le.ac.uk/handle/2381/32505.

Hessler, D.M. et al. (2017) ‘Diabetes distress is linked with worsening diabetes management over time in adults with Type 1 diabetes’, Diabetic Medicine, 34(9), pp. 1228–1234. Available at: https://doi.org/10.1111/dme.13381.

Holt, R.I.G. (2010a) Textbook of diabetes. 4th ed. Chichester: Wiley-Blackwell. Available at: http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077.

Holt, R.I.G. (2010b) Textbook of diabetes. 4th ed. Chichester: Wiley-Blackwell. Available at: http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077.

Holt, R.I.G. (2010c) Textbook of diabetes. 4th ed. Chichester: Wiley-Blackwell. Available at: http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077.

Holt, R.I.G. (2010d) Textbook of diabetes. 4th ed. Chichester: Wiley-Blackwell. Available at: http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077.

Holt, R.I.G. (2010e) Textbook of diabetes. 4th ed. Chichester: Wiley-Blackwell. Available at: http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077.

Holt, R.I.G. (2010f) Textbook of diabetes. 4th ed. Chichester: Wiley-Blackwell. Available at: http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077.

Holt, R.I.G. (2010g) Textbook of diabetes. 4th ed. Chichester: Wiley-Blackwell. Available at: http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077.

Holt, R.I.G. (2010h) Textbook of diabetes. 4th ed. Chichester: Wiley-Blackwell. Available at: http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077.

Holt, R.I.G. (2010i) Textbook of diabetes. 4th ed. Chichester: Wiley-Blackwell. Available at: http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077.

Holt, R.I.G. (2010j) Textbook of diabetes. 4th ed. Chichester: Wiley-Blackwell. Available at: http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077.

Holt, R.I.G. et al. (2016a) Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated. Available at: http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056.

Holt, R.I.G. et al. (2016b) Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated. Available at: http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056.

Holt, R.I.G. et al. (2016c) Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated. Available at: http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056.

Holt, R.I.G. et al. (2016d) Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated. Available at: http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056.

Holt, R.I.G. et al. (2016e) Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated. Available at: http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056.

Holt, R.I.G. et al. (2016f) Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated. Available at: http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056.

Holt, R.I.G. et al. (2016g) Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated. Available at: http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056.

Holt, R.I.G. et al. (2016h) Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated. Available at: http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056.

Holt, R.I.G. et al. (2016i) Textbook of Diabetes. 5th ed. Somerset: John Wiley & Sons, Incorporated. Available at: http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056.

Inzucchi, S.E. et al. (2015) ‘Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes’, Diabetes Care, 38(1), pp. 140–149. Available at: https://doi.org/10.2337/dc14-2441.

Jelinek, H.F. et al. (2016) ‘Data analytics identify glycated haemoglobin co-markers for type 2 diabetes mellitus diagnosis’, Computers in Biology and Medicine, 75, pp. 90–97. Available at: https://doi.org/10.1016/j.compbiomed.2016.05.005.

John M Jakicic (2005) ‘Physical activity considerations for the treatment and prevention of obesity’, The American Journal of Clinical Nutrition, 82(1), pp. 226S-229S. Available at: http://ajcn.nutrition.org/content/82/1/226S.

Johnston, B.C. et al. (2014) ‘Comparison of Weight Loss Among Named Diet Programs in Overweight and Obese Adults’, JAMA, 312(9). Available at: https://doi.org/10.1001/jama.2014.10397.

Jones, A.G. and Hattersley, A.T. (2013) ‘The clinical utility of C-peptide measurement in the care of patients with diabetes’, Diabetic Medicine, 30(7), pp. 803–817. Available at: https://doi.org/10.1111/dme.12159.

Kamlesh Khunti (2015) ‘Systematic Review and Meta-Analysis of Response Rates and Diagnostic Yield of Screening for Type 2 Diabetes and Those at High Risk of Diabetes’, PLoS ONE, 10(9). Available at: https://doi.org/doi:  10.1371/journal.pone.0135702.

Kenneth Hodson (2010) ‘Gestational diabetes: emerging concepts in pathophysiology’, Obstetric Medicine, 3(4). Available at: https://doi.org/doi:  10.1258/om.2010.100025.

Latika Sahu (2009) ‘Comparison of the American Diabetes Association and World Health Organization criteria for gestational diabetes mellitus and the outcomes of pregnancy’, Obstetric Medicine, 2(4). Available at: https://doi.org/doi:  10.1258/om.2009.080049.

Lee, I.-M. (2010) ‘Physical Activity and Weight Gain Prevention’, JAMA, 303(12). Available at: https://doi.org/10.1001/jama.2010.312.

Leelarathna, L. et al. (2017) ‘Comparison of different insulin pump makes under routine care conditions in adults with Type 1 diabetes’, Diabetic Medicine, 34(10), pp. 1372–1379. Available at: https://doi.org/10.1111/dme.13412.

Leff, D.R. and Heath, D. (2009) ‘Surgery for obesity in adulthood’, BMJ, 339(sep22 1), pp. b3402–b3402. Available at: https://doi.org/10.1136/bmj.b3402.

Levin, P.A. et al. (2017) ‘Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research’, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Volume 10, pp. 123–139. Available at: https://doi.org/10.2147/DMSO.S130834.

‘Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes’ (2016) New England Journal of Medicine, 375(18), pp. 1797–1799. Available at: https://doi.org/10.1056/NEJMc1611289.

Liraglutide for the treatment of type 2 diabetes mellitus. TA203, Oct 2010 (no date a). Available at: https://www.nice.org.uk/guidance/ta203.

Liraglutide for the treatment of type 2 diabetes mellitus. TA203, Oct 2010 (no date b). Available at: https://www.nice.org.uk/guidance/ta203.

Managing Older People with Type 2 Diabetes: IDF Global Guideline - International Federation on Ageing (no date). Available at: https://www.ifa-fiv.org/managing-older-people-with-type-2-diabetes-idf-global-guideline/.

Marso, S.P., Daniels, G.H., et al. (2016a) ‘Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes’, New England Journal of Medicine, 375(4), pp. 311–322. Available at: https://doi.org/10.1056/NEJMoa1603827.

Marso, S.P., Daniels, G.H., et al. (2016b) ‘Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes’, New England Journal of Medicine, 375(4), pp. 311–322. Available at: https://doi.org/10.1056/NEJMoa1603827.

Marso, S.P., Bain, S.C., et al. (2016) ‘Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes’, New England Journal of Medicine [Preprint]. Available at: https://doi.org/10.1056/NEJMoa1607141.

Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence.  CG76, Jan 2009 (no date). Available at: https://www.nice.org.uk/guidance/cg76.

Merlin C. Thomas (2016) ‘Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment’, Diabetes Therapy, 7(3). Available at: https://doi.org/doi:  10.1007/s13300-016-0189-4.

Min, S.H. et al. (2017) ‘Comparison between SGLT2 inhibitors and DPP4 inhibitors added to insulin therapy in type 2 diabetes: a systematic review with indirect comparison meta-analysis’, Diabetes/Metabolism Research and Reviews, 33(1). Available at: https://doi.org/10.1002/dmrr.2818.

‘Minimizing Hypoglycemia in Diabetes: Table 1’ (2015) Diabetes Care, 38(8), pp. 1583–1591. Available at: https://doi.org/10.2337/dc15-0279.

Mishriky, B.M., Cummings, D.M. and Tanenberg, R.J. (2015) ‘The efficacy and safety of DPP4 inhibitors compared to sulfonylureas as add-on therapy to metformin in patients with Type 2 diabetes: A systematic review and meta-analysis’, Diabetes Research and Clinical Practice, 109(2), pp. 378–388. Available at: https://doi.org/10.1016/j.diabres.2015.05.025.

Moreno-Castilla, C., Mauricio, D. and Hernandez, M. (2016) ‘Role of Medical Nutrition Therapy in the Management of Gestational Diabetes Mellitus’, Current Diabetes Reports, 16(4). Available at: https://doi.org/10.1007/s11892-016-0717-7.

Narendran, P. et al. (2017) ‘Exercise to preserve β-cell function in recent-onset Type 1 diabetes mellitus (EXTOD) - a randomized controlled pilot trial’, Diabetic Medicine, 34(11), pp. 1521–1531. Available at: https://doi.org/10.1111/dme.13439.

National Obesity Observatory (no date). Available at: http://www.noo.org.uk.

Nauck, M. et al. (2014) ‘Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)’, Diabetes Care, 37(8), pp. 2149–2158. Available at: https://doi.org/10.2337/dc13-2761.

Nauck, M.A. et al. (2007) ‘Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial’, Diabetes, Obesity and Metabolism, 9(2), pp. 194–205. Available at: https://doi.org/10.1111/j.1463-1326.2006.00704.x.

Nauck, M.A. and Meier, J.J. (2016) ‘The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions’, The Lancet Diabetes & Endocrinology, 4(6), pp. 525–536. Available at: https://doi.org/10.1016/S2213-8587(15)00482-9.

‘NHS Evidence: an introduction’ (no date). Available at: http://www.solent.nhs.uk/_store/documents/nhs_evidence_guide.pdf.

Nissen, S.E. and Wolski, K. (2007) ‘Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes’, New England Journal of Medicine, 356(24), pp. 2457–2471. Available at: https://doi.org/10.1056/NEJMoa072761.

Noctor, E. and Dunne, F. (2015) ‘Postnatal testing following gestational diabetes’, The Lancet Diabetes & Endocrinology, 3(10), pp. 761–762. Available at: https://doi.org/10.1016/S2213-8587(15)00322-8.

Nolan, C.J. et al. (2015) ‘Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes’, Diabetes, 64(3), pp. 673–686. Available at: https://doi.org/10.2337/db14-0694.

‘Obesity: identification, assessment and management | Guidance and guidelines | NICE’ (no date). Available at: https://www.nice.org.uk/guidance/cg189.

Paul Craddy (2014) ‘Comparative Effectiveness of Dipeptidylpeptidase-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison’, Diabetes Therapy, 5(1). Available at: https://doi.org/doi:  10.1007/s13300-014-0061-3.

Perrin, N.E. et al. (2017) ‘The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: a systematic review and meta-analysis’, Diabetic Medicine, 34(11), pp. 1508–1520. Available at: https://doi.org/10.1111/dme.13448.

Persaud, S.J. and Jones, P.M. (2016) ‘A Wake-up Call for Type 2 Diabetes?’, New England Journal of Medicine, 375(11), pp. 1090–1092. Available at: https://doi.org/10.1056/NEJMcibr1607950.

Pickup, J.C. (2012) ‘Insulin-Pump Therapy for Type 1 Diabetes Mellitus’, New England Journal of Medicine, 366(17), pp. 1616–1624. Available at: https://doi.org/10.1056/NEJMct1113948.

Qin, L. et al. (2010) ‘Does physical activity modify the risk of obesity for type 2 diabetes: a review of epidemiological data’, European Journal of Epidemiology, 25(1), pp. 5–12. Available at: https://doi.org/10.1007/s10654-009-9395-y.

Rasouli, B. et al. (2017) ‘Serious life events and the risk of latent autoimmune diabetes in adults (LADA) and Type 2 diabetes’, Diabetic Medicine, 34(9), pp. 1259–1263. Available at: https://doi.org/10.1111/dme.13410.

Riddle, M.C. et al. (2013) ‘Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: A 24-week, randomized, placebo-controlled comparison (GetGoal-L)’, Diabetes Care, 36(9), pp. 2489–2496. Available at: https://doi.org/10.2337/dc12-2454.

Rinki Murphy (2015) ‘Monogenic diabetes and pregnancy’, Obstetric Medicine, 8(3). Available at: https://doi.org/doi:  10.1177/1753495X15590713.

Rizos, C.V., Kei, A. and Elisaf, M.S. (2016) ‘The current role of thiazolidinediones in diabetes management’, Archives of Toxicology, 90(8), pp. 1861–1881. Available at: https://doi.org/10.1007/s00204-016-1737-4.

Rotz, M.E. et al. (2015) ‘Implications of incretin-based therapies on cardiovascular disease’, International Journal of Clinical Practice, 69(5), pp. 531–549. Available at: https://doi.org/10.1111/ijcp.12572.

Ryder, B. et al. (2013) ‘ABCD position statement on GLP-1 based therapies and pancreatic damage’, Practical Diabetes, 30(9), pp. 388–391. Available at: https://doi.org/10.1002/pdi.1816.

S M Attard (2015) ‘Implications of iron deficiency/anemia on the classification of diabetes using HbA1c’, Nutrition & Diabetes, 5(6). Available at: https://doi.org/doi:  10.1038/nutd.2015.16.

Sallis, J.F. et al. (2016) ‘Progress in physical activity over the Olympic quadrennium’, The Lancet, 388(10051), pp. 1325–1336. Available at: https://doi.org/10.1016/S0140-6736(16)30581-5.

Samuel, V.T. and Shulman, G.I. (2012) ‘Intergrating Mechanisms  for Insulin Resistance: Common Threads and Missing Links’, Cell, 148(5), pp. 852–871. Available at: https://doi.org/10.1016/j.cell.2012.02.017.

Schauer, P.R. et al. (2012) ‘Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes’, New England Journal of Medicine, 366(17), pp. 1567–1576. Available at: https://doi.org/10.1056/NEJMoa1200225.

Schauer, P.R. et al. (2017a) ‘Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes’, New England Journal of Medicine, 376(7), pp. 641–651. Available at: https://doi.org/10.1056/NEJMoa1600869.

Schauer, P.R. et al. (2017b) ‘Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes’, New England Journal of Medicine, 376(7), pp. 641–651. Available at: https://doi.org/10.1056/NEJMoa1600869.

Schwartz, S.S. et al. (2016) ‘The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema’, Diabetes Care, 39(2), pp. 179–186. Available at: https://doi.org/10.2337/dc15-1585.

Sivasubramaniyam, S., Amiel, S.A. and Choudhary, P. (2017) ‘Proportion of daily capillary blood glucose readings required in the target range for target glycaemic control: shift of focus from target range to proportion in range’, Diabetic Medicine, 34(10), pp. 1456–1460. Available at: https://doi.org/10.1111/dme.13438.

Sjöström, L. et al. (2004) ‘Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery’, New England Journal of Medicine, 351(26), pp. 2683–2693. Available at: https://doi.org/10.1056/NEJMoa035622.

Srinivasan, P. et al. (2007) ‘Islet cell transplantation’, Postgraduate Medical Journal, 83(978), pp. 224–229. Available at: https://doi.org/10.1136/pgmj.2006.053447.

‘Standards of Medical Care in Diabetes--2015: Summary of Revisions’ (2015) Diabetes Care, 38(Supplement_1), pp. S4–S4. Available at: https://doi.org/10.2337/dc15-S003.

Steven, S. et al. (2016) ‘Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders’, Diabetes Care, 39(5), pp. 808–815. Available at: https://doi.org/10.2337/dc15-1942.

Steven, S. and Taylor, R. (2015) ‘Restoring normoglycaemia by use of a very low calorie diet in long- and short-duration Type 2 diabetes’, Diabetic Medicine, 32(9), pp. 1149–1155. Available at: https://doi.org/10.1111/dme.12722.

Stewart, Z.A. et al. (2016) ‘Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes’, New England Journal of Medicine, 375(7), pp. 644–654. Available at: https://doi.org/10.1056/NEJMoa1602494.

Tanner, M. (2016) ‘Review: In type 2 diabetes, adding dipeptidyl peptidase-4 inhibitors to sulphonylureas increases hypoglycemia’, Annals of Internal Medicine, 165(4). Available at: https://doi.org/10.7326/ACPJC-2016-165-4-020.

Tao, L. et al. (2015) ‘Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial’, Diabetic Medicine, 32(7), pp. 907–919. Available at: https://doi.org/10.1111/dme.12711.

The Eatwell Guide (2016). Public Health England. Available at: https://www.gov.uk/government/publications/the-eatwell-guide.

‘Type 2 diabetes in adults: management | Guidance and guidelines | NICE’ (no date). Available at: https://www.nice.org.uk/guidance/ng28.

‘Type 2 diabetes: lixisenatide | Evidence-review | Advice | NICE’ (no date). Available at: https://www.nice.org.uk/advice/esnm26/chapter/evidence-review.

‘Type 2 diabetes: prevention in people at high risk | Guidance and guidelines | NICE’ (no date). Available at: http://www.nice.org.uk/guidance/PH38.

Umpierre, D. (2011) ‘Physical Activity Advice Only or Structured Exercise Training and Association With HbA                              Levels in Type 2 Diabetes’, JAMA, 305(17). Available at: https://doi.org/10.1001/jama.2011.576.

Unit 3 – Special care groups: A practical guide to pregnancy complicated by diabetes - Diabetes & Primary Care (no date). Available at: http://www.diabetesandprimarycare.co.uk/journal-content/view/unit-3-special-care-groups-a-practical-guide-to-pregnancy-complicated-by-diabetes/?preview.

Villani, M., de Courten, B. and Zoungas, S. (2017) ‘Emergency treatment of hypoglycaemia: a guideline and evidence review’, Diabetic Medicine, 34(9), pp. 1205–1211. Available at: https://doi.org/10.1111/dme.13379.

Vloemans, A.F. et al. (2017) ‘Keeping safe. Continuous glucose monitoring (CGM) in persons with Type 1 diabetes and impaired awareness of hypoglycaemia: a qualitative study’, Diabetic Medicine, 34(10), pp. 1470–1476. Available at: https://doi.org/10.1111/dme.13429.

Wanner, C. et al. (2016) ‘Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes’, New England Journal of Medicine, 375(4), pp. 323–334. Available at: https://doi.org/10.1056/NEJMoa1515920.

William H. Polonsky,Lawrence Fisher,Jay Earles,R. James Dudl,Joel Lees,Joseph Mullan (no date) ‘Assessing psychosocial distress in diabetes: development of the Diabetes Distress Scale’, Diabetes Care [Preprint]. Available at: http://go.galegroup.com.ezproxy3.lib.le.ac.uk/ps/retrieve.do?tabID=T002&resultListType=RESULT_LIST&searchResultsType=SingleTab&searchType=AdvancedSearchForm&currentPosition=25&docId=GALE%7CA130282980&docType=Article&sort=Relevance&contentSegment=&prodId=EAIM&contentSet=GALE%7CA130282980&searchId=R15&userGroupName=leicester&inPS=true.

Yates, T. and Davies, M.J. (2017) ‘Physical activity and Type 1 diabetes: an underused therapy’, Diabetic Medicine, 34(11), pp. 1498–1499. Available at: https://doi.org/10.1111/dme.13445.

Yeh, J.S., Kushner, R.F. and Schiff, G.D. (2016) ‘Obesity and Management of Weight Loss’, New England Journal of Medicine, 375(12), pp. 1187–1189. Available at: https://doi.org/10.1056/NEJMclde1515935.

Young-Hyman, D. et al. (2017) ‘Erratum. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016;39:2126–2140’, Diabetes Care, 40(2), p. 287.1-287. Available at: https://doi.org/10.2337/dc17-er02.

Zaccardi, F. et al. (2016) ‘Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective’, Postgraduate Medical Journal, 92(1084), pp. 63–69. Available at: https://doi.org/10.1136/postgradmedj-2015-133281.